HDL and CETP Inhibition: Will This DEFINE the Future? (Q39598288)

13 September 2017

HDL and CETP Inhibition: Will This DEFINE the Future? (English)

1 reference

13 September 2017

Michael H Davidson

1

1 reference

13 September 2017

1 August 2012

1 reference

Current treatment options in cardiovascular medicine

13 September 2017

1 reference

13 September 2017

14

1 reference

13 September 2017

384-390

1 reference

13 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-012-0191-8

13 September 2017

0 references

cites work

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Update on CETP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Safety of anacetrapib in patients with or at high risk for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Effort angina in a middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: a case of cholesteryl-ester transfer protein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Erratum to “A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infraction in middle-aged men”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0191-8

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22723175

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-density lipoprotein cholesterol as the Holy Grail

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22723175

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22723175

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11936-012-0191-8

1 reference

13 September 2017

1 reference

PubMed ID

22723175